Journal profile · Pharmacology & Pharmacy
Pharmacy World & Science
ISSN 0928-1231 · NETHERLANDS · Bimonthly · Founded 1993
Pharmacy World & Science: impact factor 3.2 (journal website); subscription journal; review over 12 weeks (community reports); community-reported acceptance: easy; 0 articles in 2025.
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, Pharmacy World & Science's largest topics are Pharmacy and Medical Practices, Pharmaceutical Practices and Patient Outcomes and Analytical Methods in Pharmaceuticals, together about 44.8% of its articles. Its main subfields are Pharmacology. (generated from OpenAlex topic counts and CAS ranking data)
Widely recognized journal of the International Collaboration of Pharmacy Journal Editors (ICPJE, https://www.icpje.org/) in comportment with the Granada Statements, International Journal of Clinical Pharmacy publishes high-quality, peer-reviewed content in health services research specifically as it relates to some aspect of the medication use process. The medication use process includes but is not limited to the prescribing, preparation, dispensing, administration, adherence to, evaluation, monitoring, and outcomes associated with legend or with over-the-counter medications, incorporating the concept of clinical pharmacy which aims to optimize utilization of medicines to achieve person-centered and public health goals. The medication use process includes attitudes, perspectives, knowledge, and behaviors of any actor in this process, including prescribers, pharmacists, pharmacy personnel, other health practitioners, patients, and caregivers. As such, the Granada Group journals often refer to “pharmacy” in their title or description, as these persons are central to medication use process; however, research articles reviews, and commentaries can refer to any person involved in this process, as well as any evaluation (e.g., pharmaceoepidemiological) of the drug products themselves or systems employed to optimize the use process.The Granada Group journals share certain commonalities and also goals to improve the medication use process and the outcomes emanating from this endeavor; however, each journal has an established niche and optimally suited for certain types of manuscripts. Further description of the aims and scopes of International Journal of Clinical Pharmacy follows below:The aim of the International Journal of Clinical Pharmacy is to provide a medium for the publication of articles in the broad field of clinical pharmacy and related subjects. The editors therefore welcome original contributions on the above-mentioned fields and especially on the following: Development, implementation and evaluation of clinical pharmacy services Efficacy, effectiveness, efficiency and safety of medicines and related medical devices Adherence Applied pharmacogenomics, pharmacogenetics and personalized medicine Clinical pharmacy and medicines related policy and guideline developments Clinical pharmacy related education, training and professional development Informatics and automation Information on medicines and related medical devices Medication management Pharmaceuti
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Derek StewartPublisher website
Editorial board by country: 9 in mainland China (about 14%); most named United Kingdom 12, Mainland China 9, Portugal 6, United States 5, Australia 5 (64 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics26.5%
- Pharmaceutical Practices and Patient OutcomesMedicine11.2%
- Analytical Methods in PharmaceuticalsChemistry7.1%
- Pharmaceutical industry and healthcarePharmacology, Toxicology and Pharmaceutics5.6%
- Medical and Pharmaceutic StudiesPharmacology, Toxicology and Pharmaceutics4.5%
- Pharmaceutical studies and practicesMedicine4.3%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics3.8%
- History of Science and MedicineArts and Humanities3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEScopusMEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 3.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 3Publisher website ·
- h-index
- 80OpenAlex ·
- i10-index
- 941OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Downloads per year (publisher) 2025
- 1,000,000Publisher website ·
Articles by year OpenAlex count · 3,179 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 471 |
| 2025 | 0 | 0 | 835 |
| 2024 | 0 | 0 | 965 |
| 2023 | 0 | 0 | 1,251 |
| 2022 | 0 | 0 | 1,405 |
| 2021 | 0 | 0 | 1,553 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 1 daysPublisher website ·
- Peer review
- Single anonymous peer review, Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare6 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 3,000 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
- Not considered
- Case reports
Article types accepted10, with length limits
- brief reportThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …main text ≤ 350 words · abstract ≤ 350 words
- case reportThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …Length not stated
- correspondenceThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …Length not stated
- letterThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …Length not stated
- method paperThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …main text ≤ 4,000 words
- opinionThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …Length not stated
- original researchThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …Length not stated
- original research articleThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …Length not stated
- reviewThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …main text ≤ 350 words · abstract ≤ 350 words
- systematic reviewThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data Availability
This journal encourages authors to provide an optional statement of data availability in their article. Data Availability Statements should include information on where data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. Data availability statements can also indicate whether …
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in International Journal of Clinical Pharmacy, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Country or region
- NETHERLANDS
- Frequency
- Bimonthly
- Founded
- 1993
- ISSN
- 0928-1231
- Latest issue on the website
- Volume 48, Issue 5 (October 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Pharmacy World & Science
What is the impact factor of Pharmacy World & Science?
The journal's website gives an impact factor of 3.2 (2025); this is the journal's own figure, as LetPub lists none for it; h-index 80.
How long does peer review take at Pharmacy World & Science?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Pharmacy World & Science?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Pharmacy World & Science based?
Of the 64 board members whose country the journal's board page names, 9 (about 14%) are in mainland China; the countries named most often are United Kingdom (12), Mainland China (9) and Portugal (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Pharmacy World & Science?
The journal's website lists SCIE, Scopus, MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Pharmacy World & Science open access, and what is the APC?
Pharmacy World & Science is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .